Evidence map›Paper›PMID 21602054›Full record

ArticleCytokine2011

T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.

Navtej Kaur, Osama S Naga, Håkan Norell, Amir A Al-Khami, Matthew J Scheffel, Nitya G Chakraborty, Christina Voelkel-Johnson, Bijay Mukherji, Shikhar Mehrotra

Abstract read
In one paragraph

Article in Cytokine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Peripheral human CD4Scientific reports · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Navtej KaurDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.
Osama S Naga
Håkan Norell
Amir A Al-Khami
Matthew J Scheffel
Nitya G Chakraborty
Christina Voelkel-Johnson
Bijay Mukherji
Shikhar Mehrotra
Medical University of South Carolina · USUConn Health · US

Funding

TCR Engineered CD4 Cells as Helpers in Tumor ImmunityR01CA088059 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MUKHERJI, BIJAY · 2001 to 2012
$2.0M
Oxidative stress and AICD in memory T cell persistenceR01CA138930 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MEHROTRA, SHIKHAR · 2010 to 2014
$1.5M
Isolation and Characterization of Prostrate Antigen Specific High Affinity TCRR21CA137725 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MEHROTRA, SHIKHAR · 2009 to 2010
$357k
NCI NIH HHS R01 CA088059NCI NIH HHS R01 CA138930NCI NIH HHS R01CA138930NCI NIH HHS R01CA88059NCI NIH HHS R21 CA137725NCI NIH HHS R21CA137725
6 · The paper itself

Abstract

Persistence of effector cytotoxic T lymphocytes (CTLs) during an immunological response is critical for successfully controlling a viral infection or tumor growth. Various cytokines are known to play an important part in regulating the immune response. The IL-2 family of cytokines that includes IL-2 and IL-15 are known to function as growth and survival factors for antigen-experienced T cells. IL-2 and IL-15 possess similar properties, including the ability to induce T cell proliferation. Whereas long-term IL-2 exposure has been shown to promote apoptosis and limit CD8(+) memory T cell survival and proliferation, it is widely believed that IL-15 can inhibit apoptosis and helps maintain a memory CD8(+) T-cell population. However, mechanisms for superior outcomes for IL-15 as compared to IL-2 are still under investigation. Our data shows that human T cells cultured in the presence of IL-15 exhibit increased expression of anti-oxidant molecules glutathione reductase (GSR), thioredoxin reductase 1 (TXNDR1), peroxiredoxin (PRDX) and superoxide dismutase (SOD). An increased expression of cell-surface thiols, intracellular glutathione, and thioredoxins was also noted in IL-15 cultured T cells. Additionally, IL-15 cultured T cells showed an increase in cytolytic effector molecules. Apart from increased level of Granzyme A and Granzyme B, IL-15 cultured T cells exhibited increased accumulation of reactive oxygen (ROS) and reactive nitrogen species (RNS) as compared to IL-2 cultured T cells. Overall, this study suggests that T cells cultured in IL-15 show increased persistence not only due to levels of anti-apoptotic proteins, but also due to increased anti-oxidant levels, which is complimented by increased cytolytic effector functions.

Indexed as

AntioxidantsApoptosisCell ProliferationCells, CulturedHumansHydrogen PeroxideImmunity, InnateInterleukin-15Interleukin-2Membrane Potential, MitochondrialNitric OxideOxidantsOxidative StressReactive Nitrogen SpeciesReactive Oxygen SpeciesT-LymphocytesAntioxidantsHydrogen PeroxideInterleukin-15Interleukin-2Nitric OxideOxidantsReactive Nitrogen SpeciesReactive Oxygen Species

Identifiers

PMID21602054
PMCPMC3595556
OpenAlexW1988988639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.